# Cefazolin

NDC: 44567-840
Generic name: Cefazolin
Labeler / Manufacturer: WG Critical Care, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230518

FDA application: NDA211413

## Active ingredients

- CEFAZOLIN SODIUM: 2 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"44567-840"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=44567-840
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4f3a9248-a354-4c77-bf5b-9eed38f00219